These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34189576)

  • 1. SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma.
    Balsas P; Veloza L; Clot G; Sureda-Gómez M; Rodríguez ML; Masaoutis C; Frigola G; Navarro A; Beà S; Nadeu F; Giné E; López-Guillermo A; Martínez A; Ribera-Cortada I; Engel P; Quintanilla-Martínez L; Klapper W; Campo E; Amador V
    Blood; 2021 Dec; 138(22):2202-2215. PubMed ID: 34189576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
    Balsas P; Palomero J; Eguileor Á; Rodríguez ML; Vegliante MC; Planas-Rigol E; Sureda-Gómez M; Cid MC; Campo E; Amador V
    Blood; 2017 Jul; 130(4):501-513. PubMed ID: 28533307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.
    Ribera-Cortada I; Martinez D; Amador V; Royo C; Navarro A; Beà S; Gine E; de Leval L; Serrano S; Wotherspoon A; Colomer D; Martinez A; Campo E
    Mod Pathol; 2015 Nov; 28(11):1435-47. PubMed ID: 26360498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
    Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E
    Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX11, a key oncogenic factor in mantle cell lymphoma.
    Beekman R; Amador V; Campo E
    Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.
    Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V
    Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
    Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
    PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX11 augments BCR signaling to drive MCL-like tumor development.
    Kuo PY; Jatiani SS; Rahman AH; Edwards D; Jiang Z; Ahr K; Perumal D; Leshchenko VV; Brody J; Shaknovich R; Ye BH; Parekh S
    Blood; 2018 May; 131(20):2247-2255. PubMed ID: 29615403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
    Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
    Vegliante MC; Palomero J; Pérez-Galán P; Roué G; Castellano G; Navarro A; Clot G; Moros A; Suárez-Cisneros H; Beà S; Hernández L; Enjuanes A; Jares P; Villamor N; Colomer D; Martín-Subero JI; Campo E; Amador V
    Blood; 2013 Mar; 121(12):2175-85. PubMed ID: 23321250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.
    Sureda-Gómez M; Balsas P; Rodríguez ML; Nadeu F; De Bolòs A; Eguileor Á; Kulis M; Castellano G; López C; Giné E; Demajo S; Jares P; Martín-Subero JI; Beà S; Campo E; Amador V
    Leukemia; 2023 Feb; 37(2):408-421. PubMed ID: 36509891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma.
    Soldini D; Valera A; Solé C; Palomero J; Amador V; Martin-Subero JI; Ribera-Cortada I; Royo C; Salaverria I; Beà S; Gonzalvo E; Johannesson H; Herrera M; Colomo L; Martinez A; Campo E
    Am J Surg Pathol; 2014 Jan; 38(1):86-93. PubMed ID: 24145648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
    Beà S; Amador V
    Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
    De Bolòs A; Sureda-Gómez M; Carreras-Caballé M; Rodríguez ML; Clot G; Beà S; Giné E; Campo E; Balsas P; Amador V
    Sci Rep; 2024 Apr; 14(1):7863. PubMed ID: 38570586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balsas P, Veloza L, Clot G, et al. SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma. Blood. 2021;138(22):2202-2215.
    Blood; 2023 Sep; 142(13):1173-1176. PubMed ID: 37768692
    [No Abstract]   [Full Text] [Related]  

  • 17. Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma.
    Assis-Mendonça GR; Fattori A; Rocha RM; Lourenço GJ; Delamain MT; Nonogaki S; de Lima VCC; Colleoni GWB; de Souza CA; Soares FA; Lima CSP; Vassallo J
    BMC Cancer; 2021 Mar; 21(1):209. PubMed ID: 33648463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma.
    He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.
    Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y
    Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
    Wu B; Li J; Wang H; Wu Q; Liu H
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.